A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.

Search Database
Name Category Primary Site Code?
Vinrosidine Sulfate Chemotherapy Yes
Vinorelbine Chemotherapy Breast, lung cancer Yes
Vinleurosine Sulfate Chemotherapy Yes
Vinglycinate Sulfate Chemotherapy Yes
Vinflunine Chemotherapy Bladder, breast, lung, other Yes
Vinepidine Sulfate Chemotherapy Yes
Vindesine Chemotherapy Yes
Vincristine Chemotherapy Yes
Vinblastine Chemotherapy Yes
Vidaza Chemotherapy Myelodysplastic syndromes Yes
Vidarabine AIDS drug No
Vibrio cholera neuraminidase Biologic therapy (BRM, immunotherapy) Yes
Verteporfin Other therapy Skin cancer No
Verapamil Ancillary Agent No
Vendexta Chemotherapy Yes
Venclexta Chemotherapy Yes
Vemurafenib Chemotherapy Yes
Vaxid Biologic therapy (BRM, immunotherapy) Lymphoma Yes
VaxSyn AIDS drug Yes
Vatalanib Chemotherapy brain, Colorectal, Myeloma, other cancer Yes
Varubi Ancillary Agent No
Vapreotide Chemotherapy Yes
Vanflyta Chemotherapy Acute myeloid leukemia, AML Yes
Vandetanib Chemotherapy Breast, cervical, endometrial, NSC lung cancer, ovarian, prostate, Thyroid Yes
Vamidex Chemotherapy Colorectal, lung, other cancer, ovarian, pancreatic cancer Yes
Name Primary Site
Tam Exemestane
TT-R
TRAP
TPF
TPDCV
TPDC-FUHU
TPCH
TOAP
TIT
TIP
TIC
THP Breast
TEMP
TEE
TCHP Breast
TBP
TAXOL/CBDCA
TAD
TAC
T-MOP
T-CID
T-CAP
T-2 protocol
T-10 protocol
Stanford V
Glossary